FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 328:1581-1586 June 3, 1993 Number 22 Next

	Full Text Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods Women with ductal carcinoma in situ have been treated both by lumpectomy and by lumpectomy followed by radiation therapy, but the benefit of combined therapy is uncertain. A group of 818 women with ductal carcinoma in situ were randomly assigned to undergo lumpectomy or lumpectomy followed by breast irradiation (50 Gy). Sufficient tissue was removed that the margins of the resected specimens were histologically tumor-free. The mean duration of follow-up was 43 months (range, 11 to 86). The principal end point of the study was event-free survival, as defined by the presence of no new ipsilateral or contralateral breast cancers, regional or distant metastases, or other cancers and by no deaths from causes other than cancer.

Results Five-year event-free survival was better in the women who received breast irradiation (84.4 percent, vs. 73.8 percent for the women treated by lumpectomy alone; P = 0.001). The improvement was due to a reduction in the occurrence of second ipsilateral breast cancers; the incidence of each of the other events was similar in the two groups. Of 391 women treated by lumpectomy alone, ipsilateral breast cancer developed in 64 (16.4 percent); it was noninvasive in 32 and invasive in the remaining 32. Of 399 women treated with lumpectomy and breast irradiation, ipsilateral breast cancer developed in 28 (7.0 percent) (noninvasive in 20 and invasive in 8). The five-year cumulative incidence of second cancers in the ipsilateral breast was reduced by irradiation from 10.4 percent to 7.5 percent for noninvasive cancers and from 10.5 percent to 2.9 percent for invasive cancers (P = 0.055 and P<0.001, respectively).

Conclusions Breast irradiation after lumpectomy is more appropriate than lumpectomy alone for women with localized ductal carcinoma in situ. .

Source Information

Institutions contributing 10 or more patients to the study are listed in the Appendix, together with the names of the principal investigators.

From the National Surgical Adjuvant Breast and Bowel Project Headquarters, Rm. 914, Scaife Hall, 3550 Terrace St., Pittsburgh, PA 15261, where reprint requests should be addressed to Dr. Fisher.

Full Text of this Article

Related Letters:

Radiation Therapy for in Situ or Localized Breast Cancer
Verhoeven D., Van Marck E., van Oosterom A.T., Lagios M. D., Page D. L., Sinoff C. L., Fisher B., Redmond C. K., Fisher E., Veronesi U.
Extract | Full Text  
N Engl J Med 1993; 329:1577-1579, Nov 18, 1993. Correspondence

The NSABP Trials
Levenback C., Bross I. D., Davis N., Heitjan D. F., Altman L. K., Angell M., Kassirer J. P.
Extract | Full Text  
N Engl J Med 1994; 331:809-810, Sep 22, 1994. Correspondence

This article has been cited by other articles:

• Hwang, E. S., Miglioretti, D. L., Ballard-Barbash, R., Weaver, D. L., Kerlikowske, K., for the National Cancer Institute Breast Cancer Su, (2007). Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ. Cancer Epidemiol. Biomarkers Prev. 16: 2587-2593 [Abstract] [Full Text]  
• Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., Bast, R. C. Jr (2007). American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. JCO 25: 5287-5312 [Abstract] [Full Text]  
• Boughey, J. C., Gonzalez, R. J., Bonner, E., Kuerer, H. M. (2007). Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast. The Oncologist 12: 1276-1287 [Abstract] [Full Text]  
• Julian, T. B., Land, S. R., Fourchotte, V., Haile, S. R., Fisher, E. R., Mamounas, E. P., Costantino, J. P., Wolmark, N. (2007). Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?. Ann. Surg. Oncol. 14: 2202-2208 [Abstract] [Full Text]  
• Pinsky, R. W., Rebner, M., Pierce, L. J., Ben-David, M. A., Vicini, F., Hunt, K. A., Helvie, M. A. (2007). Recurrent Cancer After Breast-Conserving Surgery with Radiation Therapy for Ductal Carcinoma in Situ: Mammographic Features, Method of Detection, and Stage of Recurrence. Am. J. Roentgenol. 189: 140-144 [Abstract] [Full Text]  
• Sumner, W. E. III, Koniaris, L. G., Snell, S. E., Spector, S., Powell, J., Avisar, E., Moffat, F., Livingstone, A. S., Franceschi, D. (2007). Results of 23,810 Cases of Ductal Carcinoma-in-situ. Ann. Surg. Oncol. 14: 1638-1643 [Abstract] [Full Text]  
• Claus, E. B., Petruzella, S., Carter, D., Kasl, S. (2006). Quality of Life for Women Diagnosed With Breast Carcinoma in Situ. JCO 24: 4875-4881 [Abstract] [Full Text]  
• Smith, B. D., Haffty, B. G., Buchholz, T. A., Smith, G. L., Galusha, D. H., Bekelman, J. E., Gross, C. P. (2006). Effectiveness of radiation therapy in older women with ductal carcinoma in situ.. JNCI J Natl Cancer Inst 98: 1302-1310 [Abstract] [Full Text]  
• van der Velden, A. P. S., Peeters, P. H. M., Koot, V. C. M., Hennipman, A. (2006). Local Recurrences After Conservative Treatment of Ductal Carcinoma-In-Situ of the Breast Without Radiotherapy: The Effect of Age. Ann. Surg. Oncol. 13: 990-998 [Abstract] [Full Text]  
• Wong, J. S., Kaelin, C. M., Troyan, S. L., Gadd, M. A., Gelman, R., Lester, S. C., Schnitt, S. J., Sgroi, D. C., Silver, B. J., Harris, J. R., Smith, B. L. (2006). Prospective Study of Wide Excision Alone for Ductal Carcinoma in Situ of the Breast. JCO 24: 1031-1036 [Abstract] [Full Text]  
• Arpino, G., Laucirica, R., Elledge, R. M. (2005). Premalignant and In Situ Breast Disease: Biology and Clinical Implications. ANN INTERN MED 143: 446-457 [Abstract] [Full Text]  
• Katz, S. J., Lantz, P. M., Janz, N. K., Fagerlin, A., Schwartz, K., Liu, L., Deapen, D., Salem, B., Lakhani, I., Morrow, M. (2005). Patterns and Correlates of Local Therapy for Women With Ductal Carcinoma-In-Situ. JCO 23: 3001-3007 [Abstract] [Full Text]  
• Habel, L. A., Dignam, J. J., Land, S. R., Salane, M., Capra, A. M., Julian, T. B. (2004). Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ. JNCI J Natl Cancer Inst 96: 1467-1472 [Abstract] [Full Text]  
• Baxter, N. N. (2004). RESPONSE: Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast. JNCI J Natl Cancer Inst 96: 1259-1260 [Full Text]  
• Schwartz, G. F., Lagios, M. D., Silverstein, M. J. (2004). Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast. JNCI J Natl Cancer Inst 96: 1258-1259 [Full Text]  
• Mandelblatt, J. S., Schechter, C. B., Yabroff, K. R., Lawrence, W., Dignam, J., Muennig, P., Chavez, Y., Cullen, J., Fahs, M. (2004). Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women. JCO 22: 2554-2566 [Abstract] [Full Text]  
• Leonard, G. D., Swain, S. M. (2004). Ductal Carcinoma In Situ, Complexities and Challenges. JNCI J Natl Cancer Inst 96: 906-920 [Abstract] [Full Text]  
• Gold, H. T., Dick, A. W. (2004). Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast. JNCI J Natl Cancer Inst 96: 887-888 [Full Text]  
• Joseph, K.-A., El-Tamer, M., Komenaka, I., Troxel, A., Ditkoff, B. A., Schnabel, F. (2004). Predictors of Nonsentinel Node Metastasis in Patients With Breast Cancer After Sentinel Node Metastasis. Arch Surg 139: 648-651 [Abstract] [Full Text]  
• Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., Kaelin, C. M. (2004). Ductal Carcinoma in Situ of the Breast. NEJM 350: 1430-1441 [Full Text]  
• Baxter, N. N., Virnig, B. A., Durham, S. B., Tuttle, T. M. (2004). Trends in the Treatment of Ductal Carcinoma In Situ of the Breast. JNCI J Natl Cancer Inst 96: 443-448 [Abstract] [Full Text]  
• Kerlikowske, K., Molinaro, A., Cha, I., Ljung, B.-M., Ernster, V. L., Stewart, K., Chew, K., H. Moore, D. II, Waldman, F. (2003). Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy. JNCI J Natl Cancer Inst 95: 1692-1702 [Abstract] [Full Text]  
• Mamounas, E. P. (2003). NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions. Clin Med Res 1: 309-326 [Abstract] [Full Text]  
• Hwang, E. S., Kinkel, K., Esserman, L. J., Lu, Y., Weidner, N., Hylton, N. M. (2003). Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and Multicentricity. Ann. Surg. Oncol. 10: 381-388 [Abstract] [Full Text]  
• Fletcher, S. W., Elmore, J. G. (2003). Mammographic Screening for Breast Cancer. NEJM 348: 1672-1680 [Full Text]  
• Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., Marubini, E. (2002). Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer. NEJM 347: 1227-1232 [Abstract] [Full Text]  
• Morrow, M., Strom, E. A., Bassett, L. W., Dershaw, D. D., Fowble, B., Harris, J. R., O'Malley, F., Schnitt, S. J., Singletary, S. E., Winchester, D. P. (2002). Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS). CA Cancer J Clin 52: 256-276 [Abstract] [Full Text]  
• Liang, W., Burnett, C. B., Rowland, J. H., Meropol, N. J., Eggert, L., Hwang, Y.-T., Silliman, R. A., Weeks, J. C., Mandelblatt, J. S. (2002). Communication Between Physicians and Older Women With Localized Breast Cancer: Implications for Treatment and Patient Satisfaction. JCO 20: 1008-1016 [Abstract] [Full Text]  
• Wickerham, D. L. (2001). Ductal Carcinoma-In-Situ. JCO 19: 98s-100 [Full Text]  
• Cody III, H. S., Klauber-DeMore, N., Borgen, P. I., Van Zee, K. J. (2001). Is It Really Duct Carcinoma In Situ?. Ann. Surg. Oncol. 8: 617-619 [Full Text]  
• Wärnberg, F., Bergh, J., Zack, M., Holmberg, L. (2001). Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ: A Population-based Case-Control Study in Sweden. Cancer Epidemiol. Biomarkers Prev. 10: 495-499 [Abstract] [Full Text]  
• Bijker, N., Peterse, J. L., Duchateau, L., Julien, J.-P., Fentiman, I. S., Duval, C., Di Palma, S., Simony-Lafontaine, J., de Mascarel, I., van de Vijver, M. J. (2001). Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. JCO 19: 2263-2271 [Abstract] [Full Text]  
• Cohen, M. H., Hirschfeld, S., Honig, S. F., Ibrahim, A., Johnson, J. R., O'Leary, J. J., White, R. M., Williams, G. A., Pazdur, R. (2001). Drug Approval Summaries: Arsenic Trioxide, Tamoxifen Citrate, Anastrazole, Paclitaxel, Bexarotene. The Oncologist 6: 4-11 [Abstract] [Full Text]  
• Fisher, E. R., Fisher, B. (2000). Relation of a Recurrent Intraductal Carcinoma (Ductal Carcinoma In Situ) to the Primary Tumor. JNCI J Natl Cancer Inst 92: 288-289 [Full Text]  
• Waldman, F. M., DeVries, S., Chew, K. L., Moore, D. H. II, Kerlikowske, K., Ljung, B.-M. (2000). Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences. JNCI J Natl Cancer Inst 92: 313-320 [Abstract] [Full Text]  
• Vicini, F. A., Kestin, L. L., Goldstein, N. S., Chen, P. Y., Pettinga, J., Frazier, R. C., Martinez, A. A. (2000). Impact of Young Age on Outcome in Patients With Ductal Carcinoma-In-Situ Treated With Breast-Conserving Therapy. JCO 18: 296-296 [Abstract] [Full Text]  
• Harken, A. H. (1999). Enough Is Enough. Arch Surg 134: 1061-1063 [Full Text]  
• Wärnberg, F., Bergh, J., Holmberg, L. (1999). Prognosis in Women with a Carcinoma in Situ of the Breast: A Population-based Study in Sweden. Cancer Epidemiol. Biomarkers Prev. 8: 769-774 [Abstract] [Full Text]  
• Silverstein, M. J., Lagios, M. D., Groshen, S., Waisman, J. R., Lewinsky, B. S., Martino, S., Gamagami, P., Colburn, W. J. (1999). The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast. NEJM 340: 1455-1461 [Abstract] [Full Text]  
• Silverstein, M. J (1998). Fortnightly review: Ductal carcinoma in situ of the breast. BMJ 317: 734-739 [Full Text]  
• Silverstein, M. J. (1998). Ductal Carcinoma In Situ of the Breast: Controversial Issues. The Oncologist 3: 94-103 [Abstract] [Full Text]  
• Chabner, E., Schnitt, S., Harris, J. (1997). Current Management of Patients with Ductal Carcinoma-in-Situ. The Oncologist 2: 76-82 [Abstract] [Full Text]  
• Levenback, C., Bross, I. D., Davis, N., Heitjan, D. F., Altman, L. K., Angell, M., Kassirer, J. P. (1994). The NSABP Trials. NEJM 331: 809-810 [Full Text]  
• Angell, M., Kassirer, J. P. (1994). Setting the Record Straight in the Breast-Cancer Trials. NEJM 330: 1448-1450 [Full Text]  
• Fisher, E. R., Palekar, A. S., Stoner, F., Costantino, J. (1994). Mucocele-like Lesions and Mucinous Carcinoma of the Breast. INT J SURG PATHOL 1: 213-220 [Abstract]  
• Verhoeven, D., Van Marck, E., van Oosterom, A.T., Lagios, M. D., Page, D. L., Sinoff, C. L., Fisher, B., Redmond, C. K., Fisher, E., Veronesi, U. (1993). Radiation Therapy for in Situ or Localized Breast Cancer. NEJM 329: 1577-1579 [Full Text]  
• (1993). SUPPORT FOR ADJUVANT RADIOTHERAPY FOR SMALL BREAST CANCERS. JWatch General 1993: 1-1 [Full Text]  
• Swain, S. M. (1993). In Situ or Localized Breast Cancer -- How Much Treatment Is Needed?. NEJM 328: 1633-1634 [Full Text]